亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Myopic Foveoschisis Completely Resolves within 12 Months after Vitrectomy

医学 玻璃体切除术 视网膜劈裂 中央凹 扁平部 眼科 视力 黄斑裂孔 中央凹 视网膜脱离 外科 视网膜
作者
William Beaumont,Aude Couturier,Alain Gaudric,Ramin Tadayoni,Elise Philippakis
出处
期刊:Ophthalmology Retina [Elsevier BV]
卷期号:6 (12): 1221-1230 被引量:4
标识
DOI:10.1016/j.oret.2022.06.003
摘要

To assess the sequence of anatomical resolution of myopic foveoschisis (MFS) after vitrectomy.Monocentric retrospective observational case series.The files of consecutive patients with MFS who underwent vitreoretinal surgery and were followed postoperatively for at least 6 months were reviewed.Patients underwent pars plana vitrectomy for MFS. The central foveal thickness (CFT) was measured. The presence of a foveal involvement, and/or outer retinoschisis (ORS), with or without inner retinoschisis (IRS), and foveal detachment (FD) were analyzed. Anatomical success was defined as the resolution of foveal ORS and FD.The main outcome was the time to resolution of the different morphologic features of MFS after surgery.Thirty-nine eyes of 36 patients were included in the analysis. The mean follow-up was 14.8 ± 12.9 months (range, 6-84 months). Anatomical success was achieved in 82% of cases at the end of the follow-up and in > 80% of cases during the first year. The CFT was significantly decreased in 79% of cases at 3 months. Inner retinoschisis, present in 18 eyes (46%), resolved in all cases after a median time of 1 month. Foveal ORS, present in all cases, resolved in 82% of cases after a median time of 3 months. The FD, present in 23 eyes (59%), resolved in 91% of cases after a median time of 6 months. Extrafoveal ORS resolved in 59% of cases after a median time of 12 months. The mean best-corrected visual acuity significantly improved from 0.80 ± 0.64 logarithm of the minimum angle of resolution (logMAR) (Snellen Eq 20/148) to 0.48 ± 0.52 logMAR (Snellen Eq 20/70).Most MFS (80%) are completely resolved during the first year. The decrease in CFT and early resolution of IRS could be used as early biomarkers of surgical success.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zzx发布了新的文献求助10
刚刚
2秒前
nacoo发布了新的文献求助10
8秒前
zzx完成签到,获得积分10
12秒前
14秒前
大气大侠发布了新的文献求助10
18秒前
wangfaqing942完成签到 ,获得积分10
20秒前
顾矜应助科研通管家采纳,获得10
32秒前
脑洞疼应助科研通管家采纳,获得10
32秒前
墨绾菩提应助科研通管家采纳,获得30
33秒前
土豪的摩托完成签到 ,获得积分10
45秒前
大个应助张张采纳,获得10
48秒前
KY2022完成签到,获得积分10
51秒前
iShine完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
陆康完成签到,获得积分10
1分钟前
梨花月应助陆康采纳,获得10
1分钟前
2分钟前
斯文钢笔发布了新的文献求助10
2分钟前
小李老博完成签到,获得积分10
2分钟前
上官若男应助斯文钢笔采纳,获得10
2分钟前
2分钟前
ys完成签到 ,获得积分10
2分钟前
Haibara完成签到,获得积分10
2分钟前
3分钟前
zengyuewei发布了新的文献求助10
3分钟前
3分钟前
3分钟前
不吃垃圾食品完成签到 ,获得积分10
4分钟前
慕青应助黄康采纳,获得30
4分钟前
Owen应助科研通管家采纳,获得10
4分钟前
Copyright应助科研通管家采纳,获得10
4分钟前
5分钟前
5分钟前
5分钟前
5分钟前
5分钟前
5分钟前
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6967714
求助须知:如何正确求助?哪些是违规求助? 8648878
关于积分的说明 18339936
捐赠科研通 6421233
什么是DOI,文献DOI怎么找? 3088257
关于科研通互助平台的介绍 2139703
邀请新用户注册赠送积分活动 2064762